1-3 of 3
Yves Libert, PhD
Close
Sort by
Journal Articles

Cognitive Impairment, Hypoalbuminemia, High CRP Level and Past History of Gastro-Intestinal Ulcer: 4 Markers of Frailty Which Identify Older Patients with Malignant Hemopathies Who Shouldn't Benefit from Chemotherapy

Stephanie Dubruille, PhD, Cindy Kenis, PhD, Vincent Thibaud, MD, Yves Libert, PhD, Michel Delforge, MD PhD, Lissandra Dal Lago, MD, Myriam Roos, Cindy Borghgraef, PhD, Pepersack Thierry, MD PhD, Hans Wildiers, MD PhD, Dominique Bron, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4756.
https://doi.org/10.1182/blood-2018-99-118085
Published: 2018
Journal Articles

Prediction of Poor Outcome in Older Patients Receiving Chemotherapy for Malignant Lymphoma: A New Frailty Scoring

Stephanie Dubruille, PhD, Cindy Kenis, PhD, Yves Libert, PhD, Michel Delforge, MD PhD, Catherine Choffray, Myriam Roos, Aurélie Collard, Nathalie Meuleman, MD PhD, Marie Maerevoet, MD, Darius Razavi, MD PhD, Hans Wildiers, MD PhD, Dominique Bron, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2353.
https://doi.org/10.1182/blood.V128.22.2353.2353
Published: 2016
Journal Articles

Prognostic Value of Neuro-Psychological and Biological Factors in Clinically Fit Older Patients with Hematological Malignancies

Stéphanie Dubruille, M.A., Yves Libert, PhD, Marie Maerevoet, MD, Myriam Roos, Aurélie Collard, Sandrine Vandenbossche, M.A., Nathalie Meuleman, MD PhD, Darius Razavi, MD PhD, Dominique Bron, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2630.
https://doi.org/10.1182/blood.V124.21.2630.2630
Published: 2014